Fertility and cancer: Understanding the barriers to accessing information and resources.

Authors

null

Aditi Narayan

LIVESTRONG Foundation, Austin, TX

Aditi Narayan , Carla Bann , Katherine Treiman , Cindy Soloe

Organizations

LIVESTRONG Foundation, Austin, TX, RTI International, Research Triangle Park, NC, RTI International, Rockville, MD

Research Funding

Pharmaceutical/Biotech Company

Background: Some cancer treatments may lead to infertility in individuals diagnosed during their reproductive years. Infertility can affect a cancer survivor’s long-term quality of life by causing depression as well as reduced life satisfaction and increased anxiety. Addressing fertility concerns is a major component of survivorship care. Methods: In 2017 LIVESTRONG launched a national survey to assess whether patients are being informed about potential fertility risks due to a cancer diagnosis and/or related treatments; whether they are receiving necessary education and access to resources to make informed decisions about fertility preservation; and the financial burden of fertility preservation. A total of 1,064 people diagnosed with cancer between ages of 15-39 during 2006 to 2017 responded to the survey. Results: Seventy-nine percent of respondents said a health professional had discussed fertility issues with them, but only 51% were referred to a fertility specialist. Respondents diagnosed between 2011 and 2017 were more likely to report fertility discussions compared to those diagnosed between 2006 and 2010 (84% vs. 69%; p<.001), and to be referred to a fertility specialist (58% vs. 33%, p <.0001). More educated respondents and those with health insurance at time of diagnosis were more likely to report fertility discussions than those who did not (96% vs. 85%; p=.04). The most frequently discussed topics were possible risks to fertility (89%), methods of fertility preservation (70%), whether the respondent wanted any/or more children (64%), and timing for fertility preservation (50%). Insurance and financial issues were less frequently discussed: costs of fertility preservation (37%), insurance coverage (26%), and financial assistance (30%). Forty-four percent did not take steps to preserve their fertility. Conclusions: Many respondents reported not preserving fertility before treatment because they were not referred to a fertility specialist (30%) or insurance did not cover the costs (20%). All patients diagnosed in their reproductive years should be informed of infertility risks and receive information/resources on preservation options, regardless of education, income level, and insurance status.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2018 Cancer Survivorship Symposium

Session Type

Poster Session

Session Title

Poster Session B: Chronic Anticancer Therapy; Late- and Long-term Effects/Comorbitidities; Psychosocial Issues; Risk Assessment

Track

Care Coordination, Cost, and Education,Late- and Long-term Effects/Comorbidities,Health Promotion,Psychosocial Issues,Communication and Transitions,Risk Assessment,Chronic Anti-Cancer Therapy

Sub Track

Fertility

Citation

J Clin Oncol 36, 2018 (suppl 7S; abstr 116)

DOI

10.1200/JCO.2018.36.7_suppl.116

Abstract #

116

Poster Bd #

B7

Abstract Disclosures

Similar Abstracts

First Author: Warne Pedro Andrade

First Author: Antonia Pryor Leavitt

First Author: Victoria A Wytiaz